Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › CA › SAN DIEGO › ALCALA PHARMACEUTICAL INC.

ALCALA PHARMACEUTICAL INC.

NPI: 1255656153 · SAN DIEGO, CA 92108 · Clinical Medical Laboratory · NPI assigned 04/02/2010

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official SMITH, DAVID controls 20+ related entities in our dataset. Read more

$346K
Total Medicaid Paid
24,330
Total Claims
20,047
Beneficiaries
71
Codes Billed
2018-01
First Month
2022-07
Last Month

Provider Details

Authorized OfficialSMITH, DAVID (MD)
NPI Enumeration Date04/02/2010

Related Entities

Other providers sharing the same authorized official: SMITH, DAVID

ProviderCityStateTotal Paid
VIBRANTCARE OUTPATIENT REHABILITATION WEST INC PHOENIX AZ $7.56M
VIBRANTCARE OUTPATIENT REHABILITATION OF CALIFORNIA INC PINOLE CA $2.31M
PENINSULA PATHOLOGY ASSOCIATES INCORPORATED NEWPORT NEWS VA $2.29M
UNITED IMAGING CONSULTANTS, LLC LENEXA KS $1.86M
SAN MARCOS-HAYS COUNTY EMERGENCY MEDICAL SERVICES INCORPORATED SAN MARCOS TX $1.45M
HAYWOOD COUNTY BROWNSVILLE TN $1.27M
VIBRANTCARE OUTPATIENT REHABILITATION WEST INC CASA GRANDE AZ $898K
BAY HEMATOLOGY ONCOLOGY PA EASTON MD $817K
PINNACLE MEDICAL CLINIC INC SUMMIT MS $809K
NORTH SHORE PEDIATRICS, PC DANVERS MA $546K
NEW MEXICO PHYSICAL THERAPISTS INC LOS LUNAS NM $520K
GREAT LAKES PEDIATRIC SURGEONS, INC. FORT WAYNE IN $458K
EL FUTURO, INC DURHAM NC $414K
NEW MEXICO PHYSICAL THERAPISTS INC ALBUQUERQUE NM $408K
DAVID J. SMITH MD PC GRAND LEDGE MI $401K
VIBRANTCARE OUTPATIENT REHABILITATION OF CALIFORNIA INC FAIRFIELD CA $324K
VIBRANTCARE OUTPATIENT REHABILITATION WEST INC TUCSON AZ $307K
GATEWAY FOOT AND ANKLE CENTER, PLC CLARKSVILLE TN $271K
ADVANCED CARDIOVASCULAR CONSULTANTS INC CHARDON OH $240K
NEW MEXICO PHYSICAL THERAPISTS INC ALBUQUERQUE NM $162K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 7,869 $72K
2019 4,690 $73K
2020 2,983 $48K
2021 7,902 $149K
2022 886 $4K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 6,419 4,456 $112K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 5,352 4,582 $75K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 6,320 5,422 $72K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1,090 789 $61K
86328 574 452 $12K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 721 681 $4K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 88 79 $557.59
80323 27 27 $539.22
80346 53 53 $477.20
80332 53 53 $422.43
80338 52 52 $422.43
80336 52 52 $422.43
80343 52 52 $373.03
80348 27 27 $317.80
80324 39 39 $315.17
80061 Lipid panel 48 41 $299.47
82728 43 36 $281.18
80358 27 27 $270.51
80345 27 27 $242.31
83520 83 76 $232.50
80353 27 27 $222.66
84466 43 38 $214.52
80349 27 27 $207.99
80355 39 39 $206.63
86769 30 19 $202.23
83036 Hemoglobin; glycosylated (A1C) 53 46 $199.18
80329 53 53 $193.11
80321 27 27 $178.42
80361 52 52 $160.40
80359 27 27 $142.34
84481 193 183 $117.24
84403 36 35 $115.13
84443 Thyroid stimulating hormone (TSH) 103 97 $112.56
82746 220 210 $109.17
82607 149 139 $107.56
83090 95 88 $95.22
80053 Comprehensive metabolic panel 159 150 $93.44
84681 61 56 $90.75
83525 131 124 $86.99
83540 22 16 $80.24
82172 93 86 $71.86
83695 62 57 $69.68
80373 27 27 $63.56
84439 182 172 $62.09
85025 Blood count; complete (CBC), automated, and automated differential WBC count 141 134 $58.36
86141 61 56 $56.84
80368 39 39 $56.53
80366 39 39 $56.53
86160 61 56 $53.21
80352 27 27 $45.92
83615 120 113 $41.14
83992 27 27 $39.84
80177 27 27 $36.18
80203 27 27 $36.18
80183 27 27 $36.12
82150 94 87 $36.05
80178 61 56 $30.06
80155 39 39 $28.93
86431 61 56 $25.37
81003 20 18 $6.30
84252 40 40 $0.00
84591 40 40 $0.00
84446 40 40 $0.00
80199 27 27 $0.00
84425 40 40 $0.00
84207 40 40 $0.00
82180 40 40 $0.00
80175 27 27 $0.00
84597 40 40 $0.00
80159 27 27 $0.00
84590 40 40 $0.00